The findings are promising but haven't been fully replicated in humans yet
These tools allow us to visualize structural changes, including disc issues, bone spurs, or ligament thickening
Patients often report: Reduction in bloating and abdominal pain within 2-3 weeks Improved bowel movement regularity by week 4-6 Enhanced tolerance to previously problematic foods by week 8-12 Reduced systemic inflammation (measured by CRP, ESR) after 12 weeks of consistent use BPC-157 for Musculoskeletal Healing: Tendons, Ligaments, and Joints For musculoskeletal applications, BPC-157 is typically administered via subcutaneous injection near the injury site
GHK-Cu, by contrast, appears to act more directly on fibroblast signaling and collagen gene transcription, with VEGF upregulation occurring as part of a broader tissue remodeling response
Extending half-life by 4060% means fewer injections, steadier fibroblast signaling, and higher cumulative dermal exposure at lower total peptide dose
Recent research has broadened its applications beyond metabolism, highlighting its synergistic potential with NAD+ therapy for anti-aging and longevity benefits.[6][7] For instance, studies in adipocytes have demonstrated that 5-Amino-1MQ can increase NAD+ levels by 1.2 to 1.6-fold, suggesting a direct role in cellular rejuvenation.[8] This evidence prompted HyperCharge Health to incorporate NAD+ therapy with 5-Amino-1MQ, particularly for adults over 40, where NAD+ levels may have dropped by 50% or more.[9][10] At our clinics, we've observed patients reporting not just improved energy but also enhanced skin elasticity and reduced inflammation markers after combining these therapies
/assets/docs/446094.jpg)
